Skip to main content
SpringerLink
Log in

Treatment Dilemmas in Patients with Synchronous Colorectal Liver Metastases

  • Conference paper
  • First Online:
Early Gastrointestinal Cancers

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 196))

Abstract

Approximately 20 % of patients with colorectal cancer have synchronous liver metastases at the time of diagnosis. In some instances it is difficult to determine the best treatment strategy in these patients. For example, should the primary tumor be removed in those patients with unresectable liver metastases and who do not have any symptoms of the primary tumor? Or which operation should be performed first in patients with rectal cancer and synchronous resectable liver metastases? Unfortunately, there are no clear answers to these questions from prospective randomized trials. In the present article retrospective studies are analyzed in order to define the best possible treatment strategy for patients with synchronous colorectal liver metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adam R (2007) Colorectal cancer with synchronous liver metastases. Br J Surg 94:129–131

    Article  PubMed  CAS  Google Scholar 

  • Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052–1061

    Article  PubMed  Google Scholar 

  • Adam R, Aloia T, Lévi F, Wicherts DA, de Haas RJ, Paule B, Bralet MP, Bouchahda M, Machover D, Ducreux M, Castagne V, Azoulay D, Castaing D (2007) Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 25:4593–4602

    Article  PubMed  CAS  Google Scholar 

  • Bajwa A, Blunt N, Vyas S, Suliman I, Bridgewater J, Hochhauser D, Ledermann JA, O’Bichere A (2009) Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. Eur J Surg Oncol 35(2):164–167

    Article  PubMed  CAS  Google Scholar 

  • Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE (1981) Natural history of untreated patients with liver metastases from colorectal cancer. Am J Surg 141:586–589

    Article  PubMed  CAS  Google Scholar 

  • Benoist S, Pautrat K, Mitry E et al (2005) Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 92:1155–1160

    Article  PubMed  CAS  Google Scholar 

  • Benoist S, Brouquet A, Penna C, Julié C, El Hajjam M, Chagnon S, Mitry E, Rougier P, Nordlinger B (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945

    Article  PubMed  Google Scholar 

  • Blazer DG 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JN (2008) Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26:5344–5351

    Article  PubMed  Google Scholar 

  • Borner MM, Dietrich D, Stupp R, Morant R, Honegger H, Wernli M et al (2002) Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. J Clin Oncol 20:1759–1766

    Article  PubMed  CAS  Google Scholar 

  • Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M (2008) Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol 15:219–226

    Article  PubMed  Google Scholar 

  • Damjanov N, Weiss J, Haller DG (2009) Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist 14:963–969

    Article  PubMed  Google Scholar 

  • De Bock K, Mazzone M, Carmeliet P (2011) Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? Nat Rev Clin Oncol 8:393–404

    Article  PubMed  Google Scholar 

  • de Jong MC, van Dam RM, Maas M, Bemelmans MH, Olde Damink SW, Beets GL, Dejong CH (2011) The liver-first approach for synchronous colorectal liver metastasis: a 5 year single-centre experience. HPB (Oxford) 13:745–52

    Google Scholar 

  • Eisenberger A, Whelan RL, Neugut AI (2008) Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis 23:559–568

    Article  PubMed  Google Scholar 

  • Evans MD, Escofet X, Karandikar SS, Stamatakis JD (2009) Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer. World J Surg Oncol 7:28

    Article  PubMed  Google Scholar 

  • Galizia G, Lieto E, Orditura M, Castellano P, Imperatore V, Pinto M et al (2008) First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 143:352–358

    Article  PubMed  Google Scholar 

  • Giacchi R, Sebastiani M, Lungarotti F (1988) Natural history of synchronous hepatic metastases from a non-treated colorectal cancer. J Chir 125:419–423

    CAS  Google Scholar 

  • Grothey A, Sargent D (2005) Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line. J Clin Oncol  %20;23:9441–42

    Google Scholar 

  • Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342

    Article  PubMed  CAS  Google Scholar 

  • Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62

    Article  PubMed  CAS  Google Scholar 

  • Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S (2005) Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23:3706–3712

    Article  PubMed  CAS  Google Scholar 

  • Karoui M, Koubaa W, Delbaldo C, Charachon A, Laurent A, Piedbois P et al (2008) Chemotherapy has also an effect on primary tumor in colon carcinoma. Ann Surg Oncol 15:3440–3446

    Article  PubMed  CAS  Google Scholar 

  • Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–3683

    Article  PubMed  Google Scholar 

  • Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA (2012) Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 255:237–247

    Article  PubMed  Google Scholar 

  • Lo SS, Moffatt-Bruce S, Dawson LA, Schwarz RE, The BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman RD (2011) The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 8:405–416

    Article  PubMed  CAS  Google Scholar 

  • Lyass S, Zamir G, Matot I, Goitein D, Eid A, Jurim O (2001) Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol 78:17–21

    Article  PubMed  CAS  Google Scholar 

  • Mella J, Biffin A, Radcliffe AG et al (1997) Population-based audit of colorectal cancer management in two UK health regions. Colorectal cancer working group, Royal college of surgeons of England clinical epidemiology and audit unit. Br J Surg 84:1731–1736

    Article  PubMed  CAS  Google Scholar 

  • Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, Morel P, Rubbia-Brandt L, Majno PE (2008) ‘Liver first’ approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 25:430–435

    Article  PubMed  Google Scholar 

  • Michel P, Roque I, Di FF et al (2004) Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 28:434–437

    Article  PubMed  Google Scholar 

  • Millikan KW, Staren ED, Doolas A (1997) Invasive therapy of metastatic colorectal cancer to the liver. Surg Clin North Am 77:27–48

    Article  PubMed  CAS  Google Scholar 

  • Muratore A, Zorzi D, Bouzari H et al (2007) Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 14:766–770

    Article  PubMed  Google Scholar 

  • O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst 96:1420–1425

    Article  PubMed  Google Scholar 

  • Peeters CF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T, Ruers TJ (2004) Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. Int J Cancer 112:554–559

    Article  PubMed  CAS  Google Scholar 

  • Peeters CF et al (2005) Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery 137:246–249

    Article  PubMed  Google Scholar 

  • Peeters CF, De Waal RM, Wobbes T, Westphal JR, Ruers TJ (2006) Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer 119:1249–1253

    Article  PubMed  CAS  Google Scholar 

  • Poultsides GA, Servais EL, Saltz LB, Patil S, Kemeny NE, Guillem JG et al (2009) Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27:3379–3384

    Article  PubMed  Google Scholar 

  • Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, Barbas AS, Abdalla EK, Choti MA, Vauthey JN, Ludwig KA, Mantyh CR, Morse MA, Clary BM (2007) Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14:3481–3491

    Article  PubMed  Google Scholar 

  • Ruo L, Gougoutas C, Paty PB et al (2003) Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196:722–728

    Article  PubMed  Google Scholar 

  • Sanoff HK, Sargent DJ, Campbell ME, Morton RF, Fuchs CS, Ramanathan RK et al (2008) Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol 26:5721–5727

    Article  PubMed  CAS  Google Scholar 

  • Sarela A, O’Riordain DS (2001) Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 88:163–164

    Article  PubMed  CAS  Google Scholar 

  • Schmidt C (2009) Metastatic colorectal cancer: is surgery necessary? J Natl Cancer Inst 101:1113–1115

    Article  PubMed  Google Scholar 

  • Scoggins CR, Meszoely IM, Blanke CD et al (1999) Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 6:651–657

    Article  PubMed  CAS  Google Scholar 

  • Scheithauer W, Kornek GV, Raderer M, Schoell B, Schmid K, Kovats E, Schneeweiss B, Lang F, Lenauer A, Depisch D (2003) Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 21:1307–1312

    Article  PubMed  CAS  Google Scholar 

  • Scheer MG, Sloots CE, van der Wilt GJ, Ruers TJ (2008) Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 19(11):1829–35. (Epub 28 Jul 2008, Review)

    Google Scholar 

  • Shields AF, Zalupski MM, Marshall JL, Meropol NJ (2004) Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trial. Cancer 100:531–537

    Article  PubMed  CAS  Google Scholar 

  • Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982–999

    Article  PubMed  CAS  Google Scholar 

  • Stillwell AP, Buettner PG, Ho YH (2010) Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 34(4):797–807

    Article  PubMed  CAS  Google Scholar 

  • Tebbutt NC, Norman AR, Cunningham D et al (2003) Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 52:568–573

    Article  PubMed  CAS  Google Scholar 

  • Thelen A, Jonas S, Benckert C, Spinelli A, Lopez-Hänninen E, Rudolph B, Neumann U, Neuhaus P (2007) Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 22:1269–1276

    Article  PubMed  Google Scholar 

  • Turrini O, Viret F, Guiramand J, Lelong B, Bège T, Delpero JR (2007) Strategies for the treatment of synchronous liver metastasis. Eur J Surg Oncol 33:735–740

    Article  PubMed  CAS  Google Scholar 

  • van der Pool AE, de Wilt JH, Lalmahomed ZS, Eggermont AM, Ijzermans JN, Verhoef C (2010) Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg 97:383–390

    Article  PubMed  Google Scholar 

  • Van Dijk TH, Havenga K, Beukema J, Beets GL, Gelderblom H, de Jong KP, Rutten HJ, Van De Velde CJ, Wiggers T, Hospers G (2010) Short-course radiation therapy, neoadjuvant bevacizumab, capecitabine and oxaliplatin, and radical resection of primary tumor and metastases in primary stage IV rectal cancer: a phase II multicenter study of the Dutch colorectal cancer group. ASCO Meeting Abstract: J Clin Oncol 28:15s (suppl; abstr 3638)

    Google Scholar 

  • Vassiliou I, Arkadopoulos N, Theodosopoulos T, Fragulidis G, Marinis A, Kondi-Paphiti A, Samanides L, Polydorou A, Gennatas C, Voros D, Smyrniotis V (2007) Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations. World J Gastroenterol 13:1431–1434

    PubMed  Google Scholar 

  • Verhoef C, van der Pool AE, Nuyttens JJ, Planting AS, Eggermont AM, de Wilt JH (2009) The “liver-first approach” for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 52:23–30

    Article  PubMed  Google Scholar 

  • Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilson DM (1984) The natural history of hepatic metastases from colorectal cancer. Ann Surg 199:205–208

    Article  Google Scholar 

  • Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D (2003) Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 90:956–962

    Article  PubMed  CAS  Google Scholar 

  • Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145–147

    Article  PubMed  CAS  Google Scholar 

  • Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285–288

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands

    T. J. M. Ruers & J. Hagendoorn

Authors
  1. T. J. M. Ruers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Hagendoorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. J. M. Ruers .

Editor information

Editors and Affiliations

  1. Tumor- und Brustzentrum ZeTuP AG, Rorschacherstr. 150, St. Gallen, 9006, Switzerland

    Florian Otto

  2. Rheinstr. 2, Saarbrücken, 66113, Germany

    Manfred P. Lutz

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ruers, T., Hagendoorn, J. (2012). Treatment Dilemmas in Patients with Synchronous Colorectal Liver Metastases. In: Otto, F., Lutz, M. (eds) Early Gastrointestinal Cancers. Recent Results in Cancer Research, vol 196. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31629-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-31629-6_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-31628-9

  • Online ISBN: 978-3-642-31629-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation